The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Neuronal C/EBPβ/AEP pathway shortens life span via selective GABAnergic neuronal degeneration by FOXO repression
Open accessAbstract
The age-related cognitive decline of normal aging is exacerbated in neurodegenerative diseases including Alzheimer’s disease (AD). However, it remains unclear whether age-related cognitive regulators in AD pathologies contribute to life span. Here, we show that C/EBPβ, an Aβ and inflammatory cytokine–activated transcription factor that promotes AD pathologies via activating asparagine endopeptidase (AEP), mediates longevity in a gene dose–dependent manner in neuronal C/EBPβ transgenic mice. C/EBPβ selectively triggers inhibitory GABAnergic neuronal degeneration by repressing FOXOs and up-regulating AEP, leading to aberrant neural excitation and cognitive dysfunction. Overexpression of CEBP-2 or LGMN-1 (AEP) in Caenorhabditis elegans neurons but not muscle stimulates neural excitation and shortens life span. CEBP-2 or LGMN-1 reduces daf-2 mutant–elongated life span and diminishes daf-16 –induced longevity. C/EBPβ and AEP are lower in humans with extended longevity and inversely correlated with REST/FOXO1. These findings demonstrate a conserved mechanism of aging that couples pathological cognitive decline to life span by the neuronal C/EBPβ/AEP pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1. Neuronal C/EBPβ overexpression elicits short life span, associated with behavioral impairments in Thy1-C/EBPβ Tg mice, related to fig. S1. (A) Human C/EBPβ overexpression in neurons shortens life span. C/EBPβ Tg strain of origin: C57BL/6; P < 0.0001, log-rank test; ***P < 0.001. (B) C/EBPβ knockdown extends life span. C/EBPβ+/− strain of origin: 129S1/Sv-Oca2+ Tyr+ Kitl+; P < 0.0001, log-rank test; ***P < 0.001. (C) Left: Images from PET-CT scanning of 18F-FDG uptake in 6-month-old Thy1-C/EBPβ Tg, C/EBPβ+/−, and age-matched WT littermates. Right: Standardized uptake value (SUV) at increasing time intervals after injection of 18F-FDG. Means ± SEM; n = 3 mice per group; **P < 0.01; Mann-Whitney U test. (D) Seizure duration after administration of PTZ (35 mg kg−1). Control (WT), n = 6; C/EBPβ Tg, n = 6; C/EBPβ+/−, n = 6 mice. *P < 0.05 and **P < 0.01; Mann-Whitney U test. (E) Elevated [Ca2+]i in the C/EBPβ-overexpressing hippocampal CA1. The box plots indicate first, median, and third quartiles as well as outliers. N = 196 (WT control) and 95 cells (C/EBPβ Tg) pooled from six animals each; *P = 0.043, t(289) = 2.04; two-tailed Student’s t test. (F) PPI. Means ± SEM; n = 8 mice per group; unpaired t test with Welch’s correction. (G) Open field test. Means ± SEM; n = 8 mice per group; *P < 0.05; unpaired t test with Welch’s correction. (H) FST. Means ± SEM; n = 8 mice per group; unpaired t test with Welch’s correction. (I) Sleep latency test. Means ± SEM; n = 8 mice per group; *P < 0.05; unpaired t test with Welch’s correction. (J and K) MWM analysis of cognitive functions. Means ± SEM; n = 8 mice per group; *P < 0.05 and **P < 0.01; unpaired t test with Welch’s correction. (L) Fear condition tests. Means ± SEM; n = 8 mice per group; *P < 0.05, and **P < 0.01; unpaired t test with Welch’s correction.](https://figures.cochat.ai/paper-figures/7ac6299393914d238c4ffe85f82b8535/neuronal-c-ebp-aep-pathway-shortens-life-span-via-selective-gabanergic-neuronal-figure-1.jpg)


![Fig. 4. Neuronal C/EBPβ represses REST and FOXO1 expression in the brain, related to figs. S5 to S7. (A and B) Rat primary neurons (DIV 12) were infected with lentivirus expressing FOXO1 or C/EBPβ, sh-FOXO1, or sh-C/EBPβ for 72 hours. Neurons were harvested for real-time PCR (A) and WB (B). Control, vector virus. (Means ± SEM; *P < 0.05 and **P < 0.01; n = 3; two-way ANOVA and Bonferroni’s post hoc test). (C) The LAP/LIP isoform ratios were calculated from quantification by immunoblots of (B). Data are represented as means ± SEM; n = 4 per group. **P < 0.01; two-way ANOVA and Bonferroni’s post hoc test. (D) Luciferase assay. Human REST and FOXO1 promoter luciferase plasmids were cotransfected into SH-SY5Y cells with C/EBPβ–green fluorescent protein (GFP) overexpression plasmid for 48 hours. The luciferase activities were calculated by using the Luciferase Reporter Assay System, which indicated the promoter activities. (Means ± SEM; **P < 0.01; n = 3; one-way ANOVA). RLU, relative light units. (E) Chromatin immunoprecipitation (ChIP) assay. ChIP assay was performed to detect the binding sites of C/EBPβ on the human REST and FOXO1 promoters. The DNA-protein cross-linking ChIP samples were immunoprecipitated with anti-C/EBPβ antibody or immunoglobulin G (IgG). After reversing cross-links, PCR was performed by using primer pairs at −1409 to −1189 (REST) or −1587 to −1357 (FOXO1) of the PCR assays that also detected each input sample. Genomic DNA samples were pulled down with anti–histone H3 and normalized by glyceraldehyde phosphate dehydrogenase (GAPDH) primers as positive control. The equal amount of input was confirmed with REST and FOXO1. (F) EMSA. Nuclear extract proteins (NE) were isolated from SH-SY5Y cells transfected with C/EBPβ-GFP for 48 hours. EMSA was used to detect the C/EBPβ binding ability on sites −1250 to −1260 (REST) or −1504 to −1495 (FOXO1) promoter [ATGTTGTAATA (REST) or TTTACTTAAC (FOXO1)], mutation probe 1 [GCGTTGTAATA (REST) or TTTACTTGGC (FOXO1)] or mutation probe 2 [(ATTTTGTAATA (REST) or TTTACTTAAT (FOXO1)], and supershift. Data are representative of three independent experiments.](https://figures.cochat.ai/paper-figures/71fdc4e95f444c9091742fb0b82036ae/neuronal-c-ebp-aep-pathway-shortens-life-span-via-selective-gabanergic-neuronal-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of the transcription factor C/EBPβ has been found to increase with age, resulting in the activation of AEP (also known as δ-secretase) transcription and ultimately leading to excitatory neurotoxicity and a shortened lifespan.398”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [398]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Timmons, L., Court, D. L., & Fire, A. (2001) · Gene · doi:10.1016/s0378-1119(00)00579-5 · Cited by 1,843
Lin, K., Dorman, J. B., Rodan, A., & Kenyon, C. (1997) · Science · doi:10.1126/science.278.5341.1319 · Cited by 1,495
Religious Orders Study and Rush Memory and Aging Project
Bennett, D. A., Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., & Schneider, J. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179939 · Cited by 1,260
Self-citationLin, K., Hsin, H., Libina, N., & Kenyon, C. (2001) · Nature Genetics · doi:10.1038/88850 · Cited by 1,039
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Opposing activities protect against age-onset proteotoxicity
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843
A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life Span
Lehtinen, M. K., Yuan, Z., Boag, P. R., Yang, Y., Villén, J., Becker, E. B. E., DiBacco, S., de la Iglesia, N., Gygi, S., Blackwell, T. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.046 · Cited by 839
Broughton, S. J., Piper, M. D. W., Ikeya, T., Bass, T. M., Jacobson, J., Driege, Y., Martinez, P., Hafen, E., Withers, D. J., Leevers, S. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405775102 · Cited by 822
Cited by
Dietary regulation in health and disease
Wu, Q., Gao, Z.-J., Yu, X., & Wang, P. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01104-w · Cited by 176
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Self-citationXia, Y., Xiao, Y., Wang, Z.-H., Liu, X., Alam, A. M., Haran, J. P., McCormick, B. A., Shu, X., Wang, X., & Ye, K. (2023) · Nature Communications · doi:10.1038/s41467-023-41283-w · Cited by 108
Self-citationHe, W., Zhang, S., Qi, Z., & Liu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107201 · Cited by 33
C/ EBPβ : A transcription factor associated with the irreversible progression of Alzheimer's disease
Yao, Q., Long, C., Yi, P., Zhang, G., Wan, W., Rao, X., Ying, J., Liang, W., & Hua, F. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14721 · Cited by 29
Durand, A., Bonilla, N., Level, T., Ginestet, Z., Lombès, A., Guichard, V., Germain, M., Jacques, S., Letourneur, F., Cruzeiro, M. D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45984-8 · Cited by 21
Targeting PGE2 mediated senescent neuron improves tumor therapy
Zhao, J., Wu, L., Cai, G., Ou, D., Liao, K., Yang, J., Zhou, L., Huang, R., Lin, S., Huang, X., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf045 · Cited by 20
López‐Cerdán, A., Andreu, Z., Hidalgo, M. R., Soler-Sáez, I., Porlan, A., Pozo‐Morales, M., León, S., de la Iglesia-Vayá, M., Mikozami, A., Guerini, F. R., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106605 · Cited by 14
Cholestanol accelerates α-synuclein aggregation and spreading by activating asparagine endopeptidase
Yu, T., Nie, S., Bu, L., Liu, M., He, J., Niu, X., Feng, H., Guo, J., Tang, B., Zhang, Z., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.165841 · Cited by 13
Self-citationMitochondria, Autophagy and Inflammation: Interconnected in Aging
Silva, R. C. M. C. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01231-x · Cited by 13
Gao, W. H., Dong, Q., Wu, X., Wang, Y., Li, J., Zhang, Q., Lu, F., & Liu, F. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00164 · Cited by 12
Distinct factors drive the progression of tau pathology in Alzheimer’s disease
Luo, Y., Yu, H., & Ye, K. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.04.001 · Cited by 12
Self-citationWang, J., Li, Y., & Xia, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1656165 · Cited by 12
Self-citationZhu, T., Bai, S., Wu, G., Zhai, S., Zhang, P., Fu, C., & Longjiang, Y. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118284 · Cited by 11
Development of asparagine endopeptidase inhibitors for treating neurodegenerative diseases
Meng, X., Li, B., Wang, M., Zheng, W., & Ye, K. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.01.009 · Cited by 10
Self-citationC/EBPβ in Alzheimer’s disease: An integrative regulator of pathological mechanisms
Luo, X., Liang, J., Lei, X., Sun, F., Gong, M., Liu, B., & Zhou, Z. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111198 · Cited by 8
Treating Alzheimer’s Disease: Focusing on Neurodegenerative Consequences
Sun, M., & Alkon, D. L. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240479 · Cited by 8
Neuronal C/EBPβ Shortens the Lifespan via Inactivating NAMPT
Li, B., Xie, Z., Wang, M., Nie, S., Qian, Z., Meng, X., Liu, X., Kang, S. S., & Ye, K. (2025) · Advanced Science · doi:10.1002/advs.202414871 · Cited by 5
Self-citationDNFE: Directed network flow entropy for detecting tipping points during biological processes
Peng, X., Qiao, R., Li, P., & Chen, L. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013336 · Cited by 5
Yang, Y., Guan, P.-P., & Wang, P. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117223 · Cited by 5
Holm, K., Song, M.-S., Samara, L., Li, H., Swiderski, P. M., Alluin, J. V., Habib, N., & Rossi, J. J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.11.031 · Cited by 4
Shyam, M., Veronica, A., Wadhwa, J., Sharma, V., Bm, O., Srirangan, P., Venkatesh, R., & Prince, S. E. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12021-4 · Cited by 4
Exploring exosomes to provide evidence for the treatment and prediction of Alzheimer’s disease
QUAN, X., MA, X., LI, G., FU, X., LI, J., & ZENG, L. (2023) · Biocell · doi:10.32604/biocell.2023.031226 · Cited by 4
Chen, X., Wang, Y., Zhang, Y., Li, X., Zhang, L., Gao, S., & Zhang, C. (2025) · Biology · doi:10.3390/biology14030272 · Cited by 4
Lou, Y., Chen, X., Zhao, L., Xuc, N., Zhang, L., Hu, W., & Qiu, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1378959 · Cited by 3
IL-18 binding protein attenuates neuroinflammation and cognitive decline in Alzheimer’s disease
Hong, D. K., Jeon, S. H., Kang, M., Lee, S., Liu, X., Ahn, E. H., & Kang, S. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03720-7 · Cited by 2
Self-citationGadd45α silencing alleviates cerebral ischemia–reperfusion injury by suppressing FOXO1 signaling
Chen, C., Tao, W., Chen, F., & Gong, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-55411-1 · Cited by 2
Kim, G. H., Kim, J., Choi, W., Kim, Y. K., Lee, K. H., Jang, J., Kim, J. G., Ryu, H. J., Yang, S.-J., Jang, H., et al. (2024) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2024.23.2.75 · Cited by 2
CaMK modulates sensory neural activity to control longevity and proteostasis
Zhao, R., Ge, W., Xue, W., Deng, Z., Liu, J., Wang, K., Jin, Y. N., & Yu, Y. V. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2423428122 · Cited by 2
Li, Z., Feng, L., Wei, X., Liu, L., Zhu, Y., Wang, H., Liu, J., Luo, L., Zheng, Z., Song, B., et al. (2026) · Cell Discovery · doi:10.1038/s41421-025-00860-7 · Cited by 1
Ultra‐Processed Foods and Neuropsychiatric Disorders: A Scientometric Study
Espinoza‐Carhuancho, F., Barriga-Yauri, G., Medina, J., Quispe-Tasayco, L., Munive-Degregori, A., Calderón, K. L. M., & Mayta‐Tovalino, F. (2025) · BioMed Research International · doi:10.1155/bmri/8104780 · Cited by 1
Smith, J. J., Taylor, S. R., Destain, H., Kim, G., Hall, D. H., White, J. G., Miller, D. M., & Kratsios, P. (2026) · Nature Communications · doi:10.1038/s41467-026-76320-x · Cited by 1
Sun, Y., Yang, Y., Jiang, Z., Wang, F., Han, K. S., Hong, L., Cao, J., & Yu, M. (2022) · Reproduction · doi:10.1530/rep-22-0270 · Cited by 1
Roles of C/EBPβ/AEP in Neurodegenerative Diseases
Guo, J., Liu, X., Yang, S.-S., Li, Q., Duan, Y., Zhu, S., Zhou, K., Yan, Y.-Z., & Zeng, P. H. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266357822250119172351 · Cited by 1
Self-citationda Silva, C. L., Schwartz, G. M., Velozo, E. L., Kanan, L. A., Pimentel, G. G. D. A., & Uvinha, R. R. (2024) · doi:10.22533/at.ed.5292405041
Marins, R. D. M. C., Gonçalves, A. C. D. S., & Coelho, W. S. (2024) · doi:10.22533/at.ed.5292405044
Educação física em movimento: saúde e bem-estar através do exercício 2
da Silva, C. L. (2024) · doi:10.22533/at.ed.529240504
O JOGO DA CAPOEIRA DA BAHIA PARA O MUNDO: UM EXEMPLO DO TURISMO SUSTENTADO
Jaqueira, A. R., Vianna, J. A., & de Araújo, P. C. (2024) · doi:10.22533/at.ed.5292405042
da Silva, J. C. S., Ricardo, J. B., de Souza, L. C. T., Henrique, J., & Nolasco, R. A. (2024) · doi:10.22533/at.ed.5292405043
SÍNTESE DE IRISINA MEDIADA PELA PRÁTICA DE EXERCÍCIO FÍSICO E SEU PAPEL NA NEUROPROTEÇÃO
dos Santos, T. M., de Barros, M. D., da Silva, V. M. D. M. A., dos Santos, K. C. O., Luna, M. E. D. L., & Lima, V. L. M. (2024) · doi:10.22533/at.ed.5292405045
Xu, L., Han, C., Chun, L., Xu, X. Z. S., & Liu, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.12.589179
Xu, L., Han, C., Chun, L., Xu, X. Z. S., & Liu, J. (2024) · eLife · doi:10.7554/elife.97829
Xu, L., Han, C., Chun, L., Xu, X. Z. S., & Liu, J. (2024) · eLife · doi:10.7554/elife.97829.1
Cholestanol promotes tau pathology in a mouse model of tauopathy
Yu, T., Li, Y., Li, S., Nie, S., Feng, H., Zhang, Z., & Meng, L. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05978-1
Misciagna, S. (2025) · Directory of Open access Books (OAPEN Foundation)
Xu, L., Han, C., Chun, L., Xu, X. Z. S., & Liu, J. (2026) · eLife · doi:10.7554/elife.97829.2
Luo, Y., Qian, Z., Yuan, G., Yang, S., Gong, W., Zhai, Y., Dai, W., An, J., Liu, Y., Jiang, Q., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76209-9
Self-citationLiu, J., Zhang, F., Zhong, T., Wang, J., Lei, H., Zhao, J., Lin, F., Fan, T., He, T., Xiong, R., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03876-x
Self-citationEndothelial C/EBPβ/AEP pathway drives vascular deterioration and systemic aging
Li, B., Nie, S., Wang, M., An, J., Qian, Z., Meng, X., Edgington‐Mitchell, L. E., Zhang, Z., Yang, X., & Ye, K. (2026) · Science Advances · doi:10.1126/sciadv.aed1961
Self-citationInhibition of asparagine endopeptidase extends the lifespan and improves health span during aging
Yang, M., Meng, X., Xie, Z., Wang, M., Qian, Z., & Ye, K. (2026) · iScience · doi:10.1016/j.isci.2026.117990
Self-citation
Metadata
- Authors
- Xia, Y., Qadota, H., Wang, Z.-H., Liu, P., Liu, X., Ye, K. X., Matheny, C. J., Berglund, K., Yu, S. P., Drake, D., Bennett, D. A., Wang, X.-C., Yankner, B. A., Benian, G. M., & Ye, K.
- Affiliations
- Emory University (US)
- Harvard University (US)
- Rush University Medical Center (US)
- Department of Pathophysiology, Key Laboratory of Ministry of Education of Neurological Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Corresponding author
- Ye, Keqiang
- ORCID
- Venue
- Science Advances
- Published
- 2022-04
- Volume
- 8
- Issue
- 13
- Pages
- eabj8658-eabj8658
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8967231
- OpenAlex
- W4220755159
- Cited by
- 46
- References
- 64
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 19 · 2023: 3 · 2022: 2
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1s10od021773-01a1, P40OD010440, UL1TR002378)
- National Institute on Aging (R01AG017917, R01AG065177, R01AG015819, P30AG010161, U01AG061356, R01AG069042, P30AG066511, P30AG072975)
- National Institute of Neurological Disorders and Stroke (P30NS055077)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Keywords
- C/EBPβ, asparaginyl endopeptidase, excitotoxicity, aging, lifespan, Alzheimer's disease, age-related cognitive decline, daf-2, DAF-16, Caenorhabditis elegans neurons, transgenic mice, longevity
- MeSH terms
- Animals, Longevity, Neurons, Caenorhabditis elegans, Caenorhabditis elegans Proteins, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.